Brind.

The European Medicines Agency is dealing with manufacturer constraints and demand regarding the product Creon, with SSP being in place since May 2024, leading to calls for a government taskforce.

1 report, 1 independent Updated Jun 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The European Medicines Agency is dealing with manufacturer constraints and demand regarding the product Creon, with SSP being in place since May 2024, leading to calls for a government taskforce.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped